Država: Kanada
Jezik: engleski
Izvor: Health Canada
PANTOPRAZOLE (PANTOPRAZOLE SODIUM)
NYCOMED GMBH
A02BC02
PANTOPRAZOLE
20MG
TABLET (ENTERIC-COATED)
PANTOPRAZOLE (PANTOPRAZOLE SODIUM) 20MG
ORAL
100
Prescription
PROTON-PUMP INHIBITORS
Active ingredient group (AIG) number: 0133229002; AHFS:
CANCELLED PRE MARKET
2017-07-13
_PANTO-BYK (pantoprazole sodium) _ _ _ _ _ _Page 1 of 37 _ PRODUCT MONOGRAPH PR PANTO-BYK pantoprazole sodium enteric-coated tablets (as pantoprazole 20, 40 mg) H+, K+-ATPase Inhibitor Nycomed GmbH Byk-Gulden Strasse 2 78467 Konstanz, Germany Distributor: Takeda Canada Inc. 435 North Service Road West, 1st Floor Oakville, ON L6M 4X8 Date of Revision: February 21, 2013 SUBMISSION CONTROL NO: 161771 _PANTO-BYK (pantoprazole sodium) _ _ _ _ _ _Page 2 of 37 _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION .................................................... 3 SUMMARY PRODUCT INFORMATION ........................................................................... 3 INDICATIONS AND CLINICAL USE ................................................................................. 3 CONTRAINDICATIONS ...................................................................................................... 4 WARNINGS AND PRECAUTIONS..................................................................................... 4 ADVERSE REACTIONS ...................................................................................................... 7 DRUG INTERACTIONS ..................................................................................................... 11 DOSAGE AND ADMINISTRATION ................................................................................. 13 OVERDOSE ......................................................................................................................... 14 ACTION AND CLINICAL PHARMACOLOGY ............................................................... 14 STORAGE AND STABILITY ............................................................................................ 16 SPECIAL HANDLING INSTRUCTIONS .......................................................................... 16 DOSAGE FORMS, COMPOSITION AND PACKAGING ................................................ 17 PART II: SCIENTIFIC INFORMATION ......................................................................... 18 PHA Pročitajte cijeli dokument